 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/09/2024 |
$236.58 |
$238.04 |
$235.25 |
$237.04 |
399.20K | | 04/10/2024 |
$235.42 |
$238.41 |
$232.42 |
$237.79 |
419.00K | | 04/11/2024 |
$239.51 |
$241.37 |
$236.86 |
$237.24 |
624.00K | | 04/12/2024 |
$237.98 |
$239.40 |
$232.40 |
$232.59 |
423.60K | | 04/15/2024 |
$233.21 |
$237.93 |
$232.79 |
$235.08 |
328.00K |
|
|
| United Therapeutics is a biotechnology company. Co. markets and sells four commercial therapies in the U.S. to treat pulmonary arterial hypertension: Tyvaso® (treprostinil) Inhalation Solution (Tyvaso), which includes the Tyvaso Inhalation System; Remodulin® (treprostinil) Injection (Remodulin); Orenitram® (treprostinil) Extended-Release Tablets; and Adcirca® (tadalafil) Tablets. Tyvaso has also been approved to treat pulmonary hypertension associated with interstitial lung disease. In the U.S., Co. also markets and sells an oncology product, Unituxin® (dinutuximab) Injection, which is approved for treatment of high-risk neuroblastoma, and the Remunity® Pump for Remodulin. | |
|
United Therapeutics (UTHR) has the following price history information. Looking back at UTHR historical stock prices for the last five trading days, on April 09, 2024, UTHR opened at $236.58, traded as high as $238.04 and as low as $235.25, and closed at $237.04. Trading volume was a total of 399.20K shares. On April 10, 2024, UTHR opened at $235.42, traded as high as $238.41 and as low as $232.42, and closed at $237.79. Trading volume was a total of 419.00K shares. On April 11, 2024, UTHR opened at $239.51, traded as high as $241.37 and as low as $236.86, and closed at $237.24. Trading volume was a total of 624.00K shares. On April 12, 2024, UTHR opened at $237.98, traded as high as $239.40 and as low as $232.40, and closed at $232.59. Trading volume was a total of 423.60K shares. On April 15, 2024, UTHR opened at $233.21, traded as high as $237.93 and as low as $232.79, and closed at $235.08. Trading volume was a total of 328.00K shares.
UTHR Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into United Therapeutics shares, starting with a $10,000 purchase of UTHR, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/17/2014 |
|
| End date: |
04/15/2024 |
|
| Start price/share: |
$96.20 |
|
| End price/share: |
$235.08 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
144.37% |
|
| Average Annual Total Return: |
9.34% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$24,428.51 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/09/2024 | $237.04 | | 04/10/2024 | $237.79 | | 04/11/2024 | $237.24 | | 04/12/2024 | $232.59 | | 04/15/2024 | $235.08 |
|
|
Free UTHR Email Alerts:
